Location History:
- Pearland, TX (US) (2012 - 2019)
- Houston, TX (US) (2016 - 2019)
Company Filing History:
3 out of 34 
2 out of 3 
1 out of 4,455 
Years Active: 2012-2019
Title: Michael M Savage: Innovator in Pharmaceutical Applications
Introduction
Michael M Savage is a notable inventor based in Pearland, Texas, with a focus on pharmaceutical innovations. He holds a total of six patents that contribute to advancements in medical treatments and methodologies. His work primarily revolves around integrin-targeting compounds and their applications in treating various pathophysiological conditions.
Latest Patents
Among his latest patents is a method involving propionic acid derivatives aimed at antagonizing the action of an α4-integrin. This patent outlines pharmaceutical compositions that utilize specific compounds or their acceptable salts to treat various conditions. Another significant patent focuses on agonists that enhance the binding of integrin-expressing cells to integrin receptors. This method involves treating cells in vitro with integrin agonists and subsequently contacting them with integrin-binding ligands, which can lead to therapeutic applications in mammals.
Career Highlights
Michael has worked with prominent organizations such as the Texas Heart Institute and Aviara Pharmaceuticals, Inc. His experience in these institutions has allowed him to develop and refine his innovative approaches to pharmaceutical science.
Collaborations
Throughout his career, Michael has collaborated with esteemed colleagues, including Ronald J Biediger and Robert V Market. These partnerships have contributed to the successful development of his patented technologies.
Conclusion
Michael M Savage's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his significant role as an inventor. His work continues to influence the development of treatments that target integrin-related conditions.